Effectiveness of drug treatment in adult ADHD
Phil Asherson is Professor of Clinical and Molecular Psychiatry at MRC Social Genetic and Developmental Psychiatry, Institute of Psychiatry, King’s College London.
Website(s)
Suggested reading
- Asherson, P. (2005). Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 5, 525-39. [link]
- Asherson, P. & Gurling, H. (2012). Quantitative and molecular genetics of ADHD. Curr Top Behav Neurosci 9, 239-72. [link]
- Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugue, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., Gaillac, V., Ginsberg, Y., Henry, C., Krause, J., Lensing, M. B., Manor, I., Niederhofer, H., Nunes-Filipe, C., Ohlmeier, M. D., Oswald, P., Pallanti, S., Pehlivanidis, A., Ramos-Quiroga, J. A., Rastam, M., Ryffel-Rawak, D., Stes, S. & Asherson, P. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 10, 67. [link]